1
van Doesum, Jaap, Chinea, Anabelle, Pagliaro, Maria, Pasquini, Maria Cristina, van Meerten, Tom, Bakker, Martijn, Ammatuna, Emanuele
Veröffentlicht in: van Doesum , J , Chinea , A , Pagliaro , M , Pasquini , M C , van Meerten , T , Bakker , M & Ammatuna , E 2020 , ' Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases : a retrospective case study in four hospitals in Italy, Spain and the Netherlands ' , Leukemia , vol. 34 , no. 9 , pp. 2536-2538 . https://doi.org/10.1038/s41375-020-0960-4;
2020
Veröffentlicht in: van Doesum , J , Chinea , A , Pagliaro , M , Pasquini , M C , van Meerten , T , Bakker , M & Ammatuna , E 2020 , ' Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases : a retrospective case study in four hospitals in Italy, Spain and the Netherlands ' , Leukemia , vol. 34 , no. 9 , pp. 2536-2538 . https://doi.org/10.1038/s41375-020-0960-4;
2020
2
3
Spanjaart, Anne M., Pennings, Elise R.A., Mutsaers, Pim G.N.J., van Dorp, Suzanne, Jak, Margot, van Doesum, Jaap A., de Boer, Janneke W., Niezink, Anne G.H., Kos, Milan, Vermaat, Joost S.P., Sijs-Szabo, Aniko, van der Poel, Marjolein W.M., Nijhof, Inger S., Kuipers, Maria T., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Doorduijn, Jeanette K., Serroukh, Yasmina I.M., Minnema, Monique C., van Meerten, Tom, Kersten, Marie José
Veröffentlicht in: on behalf of the Dutch CAR-T Tumorboard Consortium , Spanjaart , A M , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023
Veröffentlicht in: on behalf of the Dutch CAR-T Tumorboard Consortium , Spanjaart , A M , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023